Healthy Clinical Trial
Official title:
Influence of Probiotics on Body Composition and Health in Occupational Shift Workers
NCT number | NCT02951689 |
Other study ID # | 16-1397 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | September 2016 |
Est. completion date | January 2018 |
Verified date | September 2018 |
Source | University of North Carolina, Chapel Hill |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Purpose: To evaluate the influence of probiotic supplementation on body composition and other
markers of health in occupational shift-workers.
Participants: Healthy, overweight females (ages 22-55 yrs) who are employed on a
shift-working schedule.
Procedures (methods): In a randomized, placebo-controlled intervention, subjects will
complete 3 different testing sessions (pre-screening, 1 baseline, 1 post-testing session) as
well as a 6-week intervention period. Prescreening will include written informed consent, a
health history questionnaire, baseline anthropometric measures, assessment of resting heart
rate, and exercise protocol familiarization. Baseline testing will involve body composition,
a fasted blood draw, mood surveys, and an exercise treadmill test. Subjects will be
randomized to a treatment group (multi-strain probiotic or placebo) for 6 weeks of
supplementation that includes 2 electronic contacts, followed by post-testing that will occur
in the same fashion as baseline testing.
Status | Completed |
Enrollment | 45 |
Est. completion date | January 2018 |
Est. primary completion date | January 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 22 Years to 55 Years |
Eligibility |
Inclusion Criteria: - Healthy, pre-menopausal women - Currently employed on a shift-working (rotating, evening, or night) schedule and has maintained this schedule = 6 months prior to enrollment - Participant agrees to maintain usual activity lifestyle - Participant has a body mass index of =25 kg/m2 - Participant has provided written and dated informed consent to participate in the study - Participant is willing and able to comply with the protocol - Participant is apparently healthy and free from disease, as determined by a health history questionnaire - Participant agrees to abstain from smoking, caffeine, tobacco, and alcohol before testing days - Participant is not currently pregnant and does not desire to become pregnant in the next 8 weeks. Exclusion Criteria: - Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders - Participant is using, or has used a probiotic supplements within 8 weeks prior to enrollment - Participant has lost or gained greater than 8 pounds within the previous 2 months - Participant is in, or has participated in another clinical trial within 4 weeks prior to enrollment - Participant had or currently has a self-identified eating disorder - Participant is pregnant or plans on becoming pregnant - Participant has a known allergy or sensitivity to any ingredient in the test product or placebo (determined from health history questionnaire) |
Country | Name | City | State |
---|---|---|---|
United States | Applied Physiology Laboratory | Chapel Hill | North Carolina |
Lead Sponsor | Collaborator |
---|---|
University of North Carolina, Chapel Hill | National Strength and Conditioning Association Foundation, Winclove Probiotics |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visceral Fat | measured by ultrasound | 6 weeks | |
Secondary | Ratio of fat in the abdominal region vs. hip region | Measured from dual energy x-ray absorptiometry | 6 weeks | |
Secondary | Body Fat | measured from dual energy x-ray absorptiometry | 6 weeks | |
Secondary | Lean body mass | measured from dual energy x-ray absorptiometry | 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |